Renishaw Announces Completion of Clinical Trial Extension Study, Using its Innovative Drug Delivery System in the Investigation of CDNF as a Treatment for Parkinson’s Disease

August 2020 – Global engineering technologies company, Renishaw, is pleased to announce that its award-winning neuroinfuse™ drug delivery device, the only platform currently to allow for repeated, intermittent infusions into the parenchyma, has continued to safely and effectively deliver infusions as part of an extension Read More »

Renishaw Logo (Image courtesy of Renishaw)